UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 318

Sortiert nach

Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial

Journal of cancer survivorship, 2018-08, Vol.12 (4), p.431-440

2018

Link zum Volltext

Verfügbarkeit prüfen

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

BMC cancer, 2022-04, Vol.22 (1), p.407-407, Article 407

2022

Link zum Volltext

Verfügbarkeit prüfen

Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial

Cancer medicine (Malden, MA), 2023-03, Vol.12 (5), p.6190-6199

2023

Link zum Volltext

Verfügbarkeit prüfen

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells

Cancer research (Chicago, Ill.), 2006-06, Vol.66 (12), p.6412-6420

2006

Link zum Volltext

Verfügbarkeit prüfen

The ERBB4/HER4 Receptor Tyrosine Kinase Regulates Gene Expression by Functioning as a STAT5A Nuclear Chaperone

The Journal of cell biology, 2004-11, Vol.167 (3), p.469-478

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer

NPJ breast cancer, 2023-05, Vol.9 (1), p.41-41, Article 41

2023

Link zum Volltext

Verfügbarkeit prüfen

Unusual recurrent metastasizing benign breast papilloma: a case report

Journal of medical case reports, 2020-02, Vol.14 (1), p.33-7, Article 33

2020

Link zum Volltext

Verfügbarkeit prüfen

A look at current and potential treatment approaches for hormone receptor‐positive, HER2‐negative early breast cancer

Cancer, 2022-06, Vol.128 (S11), p.2209-2223

2022

Link zum Volltext

Verfügbarkeit prüfen

Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer

Cancer epidemiology, biomarkers & prevention, 2023-02, Vol.32 (2), p.167-174

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events

Clinical lung cancer, 2022-12, Vol.23 (8), p.686-693

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting PIK3CA Alterations in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2–Negative Advanced Breast Cancer: New Therapeutic Approaches and Practical Considerations

Clinical breast cancer, 2020-08, Vol.20 (4), p.e439-e449

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices

Future oncology (London, England), 2022-03, Vol.18 (7), p.849-858

2022

Link zum Volltext

Verfügbarkeit prüfen

"Nobody Will Tell You. You've Got to Ask!": An Examination of Patient-Provider Communication Needs and Preferences among Black and White Women with Early-Stage Breast Cancer

Health communication, 2021-09, Vol.36 (11), p.1331-1342

2021

Link zum Volltext

Verfügbarkeit prüfen

A qualitative exploration of race‐based differences in social support needs of diverse women with breast cancer on adjuvant therapy

Psycho-oncology (Chichester, England), 2019-03, Vol.28 (3), p.570-576

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study

Clinical breast cancer, 2021-12, Vol.21 (6), p.539-551

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Everolimus and Capecitabine in Metastatic HER2− Breast Cancer

Clinical breast cancer, 2017-10, Vol.17 (6), p.418-426

2017

Link zum Volltext

Verfügbarkeit prüfen

Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research

Contemporary clinical trials, 2024-02, Vol.137, p.107416-107416, Article 107416

2024

Link zum Volltext

Verfügbarkeit prüfen

Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer

Journal of the National Comprehensive Cancer Network, 2017-03, Vol.15 (3), p.284

2017

Link zum Volltext

Verfügbarkeit prüfen

Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer

Journal of cancer survivorship, 2023-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer

JAMA network open, 2022-08, Vol.5 (8), p.e2225485-e2225485

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of a Prognostic Factor Index Among Women With HR+/HER2− Metastatic Breast Cancer in a Community Oncology Setting

Clinical breast cancer, 2021-08, Vol.21 (4), p.317-328.e7

2021

Link zum Volltext

Verfügbarkeit prüfen

27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study

Clinical lung cancer, 2023-03, Vol.24 (2), p.137-144

2023

Link zum Volltext

Verfügbarkeit prüfen

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Nature communications, 2018-03, Vol.9 (1), p.1219-9, Article 1219

2018

Link zum Volltext

Verfügbarkeit prüfen

Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting

JCO oncology practice, 2024-03, Vol.20 (3), p.370

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(297)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(25)
The American Journal Of Sports Medicine
(12)
Cancer Research
(11)
Plos One
(8)
Plos Genetics
(6)
Plos Pathogens
(5)
Advanced Materials
(4)
Bulletin Du Cancer
(4)
Clinical Breast Cancer
(4)
Jama Network Open
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells

The ERBB4/HER4 Receptor Tyrosine Kinase Regulates Gene Expression by Functioning as a STAT5A Nuclear Chaperone

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer

Unusual recurrent metastasizing benign breast papilloma: a case report

A look at current and potential treatment approaches for hormone receptor‐positive, HER2‐negative early breast cancer

Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer

Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events

Targeting PIK3CA Alterations in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2–Negative Advanced Breast Cancer: New Therapeutic Approaches and Practical Considerations

Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices

"Nobody Will Tell You. You've Got to Ask!": An Examination of Patient-Provider Communication Needs and Preferences among Black and White Women with Early-Stage Breast Cancer

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results

A qualitative exploration of race‐based differences in social support needs of diverse women with breast cancer on adjuvant therapy

Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study

Phase I Trial of Everolimus and Capecitabine in Metastatic HER2− Breast Cancer

Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research

Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer

Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer

Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer

Development of a Prognostic Factor Index Among Women With HR+/HER2− Metastatic Breast Cancer in a Community Oncology Setting

27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting

Suchergebnisse filtern